{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T08:08:40Z","timestamp":1790410120805,"version":"4.1.0"},"reference-count":87,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.taap.2014.06.014","type":"journal-article","created":{"date-parts":[[2014,6,23]],"date-time":"2014-06-23T10:47:12Z","timestamp":1403520432000},"page":"467-476","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":79,"title":["Di-22:6-bis(monoacylglycerol)phosphate: A clinical biomarker of drug-induced phospholipidosis for drug development and safety assessment"],"prefix":"10.1016","volume":"279","author":[{"given":"Nanjun","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Tengstrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Chourb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank Y.","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.taap.2014.06.014_bb0005","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1161\/01.CIR.72.5.1064","article-title":"Amiodarone and its desethyl metabolite: tissue distribution and morphologic changes during long-term therapy","volume":"72","author":"Adams","year":"1985","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.taap.2014.06.014_bb0010","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3341\/kjo.2011.25.5.355","article-title":"Vortex keratopathy in a patient receiving vandetanib for non-small cell lung cancer","volume":"25","author":"Ahn","year":"2011","journal-title":"Korean J. Ophthalmol."},{"key":"10.1016\/j.taap.2014.06.014_bb0015","doi-asserted-by":"crossref","first-page":"5134","DOI":"10.1097\/01.ASN.0000016684.07368.75","article-title":"Renal pathology in Fabry disease","volume":"13","author":"Alroy","year":"2002","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.taap.2014.06.014_bb0020","doi-asserted-by":"crossref","first-page":"5533","DOI":"10.1016\/j.febslet.2006.08.061","article-title":"Drug-induced phospholipidosis","volume":"580","author":"Anderson","year":"2006","journal-title":"FEBS Lett."},{"issue":"1","key":"10.1016\/j.taap.2014.06.014_bb0025","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.bcp.2013.03.017","article-title":"Bis(monoacylglycerol)phosphate reduces oxysterol formation and apoptosis in macrophages exposed to oxidized LDL","volume":"86","author":"Arnal-Levron","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.taap.2014.06.014_bb0030","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.taap.2006.10.015","article-title":"Biomarkers to monitor drug-induced phospholipidosis","volume":"218","author":"Baronas","year":"2007","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2014.06.014_bb0035","doi-asserted-by":"crossref","first-page":"308594","DOI":"10.1155\/2012\/308594","article-title":"Phospholipogenic pharmaceuticals are associated with a higher incidence of histological findings than nonphospholipogenic pharmaceuticals in preclinical toxicology studies","volume":"2012","author":"Barone","year":"2012","journal-title":"J. Toxicol."},{"issue":"2","key":"10.1016\/j.taap.2014.06.014_bb0040","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1289\/ehp.7337","article-title":"Urinary creatinine concentrations in the U.S. population: implications for urinary biologic monitoring measurements","volume":"113","author":"Barr","year":"2005","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.taap.2014.06.014_bb0045","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1080\/01926230701196414","article-title":"Letter to the editor","volume":"35","author":"Berridge","year":"2007","journal-title":"Toxicol. Pathol."},{"issue":"10","key":"10.1016\/j.taap.2014.06.014_bb0050","first-page":"565","article-title":"Cirrhogenic hepatitis due to perhexiline maleate: general review based upon one new case with ultrastructural study","volume":"129","author":"Bertrand","year":"1978","journal-title":"Ann. Med. Interne"},{"key":"10.1016\/j.taap.2014.06.014_bb0055","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/BF01813904","article-title":"Enzyme activities and phospholipid storage patterns in brain and spleen samples from Niemann\u2013Pick disease variants: a comparison of neuropathic and non-neuropathic forms","volume":"9","author":"Besley","year":"1986","journal-title":"J. Inherit. Metab. Dis."},{"issue":"4","key":"10.1016\/j.taap.2014.06.014_bb0060","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/ajh.20294","article-title":"Hydroxychloroquine causes severe vacuolar myopathy in a patient with chronic graft-versus-host disease","volume":"78","author":"Bola\u00f1os-Meade","year":"2005","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.taap.2014.06.014_bb0065","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1177\/0192623309348521","article-title":"Phospholipidosis in neurons caused by posaconazole, without evidence for functional neurologic effects","volume":"37","author":"Cartwright","year":"2009","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.taap.2014.06.014_bb0070","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1177\/0192623309352496","article-title":"A strategy for risk management of drug-induced phospholipidosis","volume":"37","author":"Chatman","year":"2009","journal-title":"Toxicol. Pathol."},{"issue":"41","key":"10.1016\/j.taap.2014.06.014_bb0075","doi-asserted-by":"crossref","first-page":"27871","DOI":"10.1074\/jbc.M801463200","article-title":"Lysobisphosphatidic acid controls endosomal cholesterol levels","volume":"283","author":"Chevallier","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.taap.2014.06.014_bb0080","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1001\/archopht.1981.03930010259007","article-title":"Amiodarone keratopathy: drug-induced lipid storage disease","volume":"99","author":"D'Amico","year":"1981","journal-title":"Arch. Opthalmol."},{"key":"10.1016\/j.taap.2014.06.014_bb0085","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1600-0773.1997.tb00285.x","article-title":"Contribution of lysosomal trapping to the total tissue uptake of psychotropic drugs","volume":"80","author":"Daniel","year":"1997","journal-title":"Pharmacol. Toxicol."},{"key":"10.1016\/j.taap.2014.06.014_bb0090","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1006\/taap.1999.8688","article-title":"The role of lysosomes in the cellular distribution of thioridazine and potential drug interactions","volume":"158","author":"Daniel","year":"1999","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2014.06.014_bb0095","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/BF00688135","article-title":"Experimental neurotoxicity of the anorectic fenfluramine","volume":"67","author":"Dastur","year":"1985","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.taap.2014.06.014_bb0100","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1016\/0006-2952(74)90174-9","article-title":"Lysomotrophic agents","volume":"23","author":"De Duve","year":"1974","journal-title":"Biochem. Pharmacol."},{"issue":"4","key":"10.1016\/j.taap.2014.06.014_bb0105","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/ki.1984.69","article-title":"Early effects of gentamicin, tobramycin, and amikacin on the human kidney","volume":"25","author":"DeBroe","year":"1984","journal-title":"Kidney Int."},{"issue":"8","key":"10.1016\/j.taap.2014.06.014_bb0110","doi-asserted-by":"crossref","first-page":"631","DOI":"10.7326\/0003-4819-148-8-200804150-00023","article-title":"Memantine-induced hepatitis with cholestasis in a very elderly patient","volume":"148","author":"Ferrara","year":"2008","journal-title":"Ann. Intern. Med."},{"issue":"7","key":"10.1016\/j.taap.2014.06.014_bb0115","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1016\/j.transproceed.2011.06.060","article-title":"Sirolimus-induced pneumonitis complicated by pentamidine-induced phospholipidosis in a renal transplant recipient","volume":"43","author":"Filippone","year":"2011","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.taap.2014.06.014_bb0120","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/BF00705806","article-title":"Effects of several lipidosis-inducing drugs upon the area postrema and adjacent medullary nuclei of adult rats","volume":"52","author":"Frish","year":"1980","journal-title":"Acta Neuropathol."},{"issue":"9","key":"10.1016\/j.taap.2014.06.014_bb0125","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1007\/s11064-010-0337-6","article-title":"Biological function of the cellular lipid BMP \u2014 BMP as a key activator for cholesterol sorting and membrane digestion","volume":"26","author":"Gallala","year":"2011","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.taap.2014.06.014_bb0130","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1378\/chest.107.6.1763","article-title":"Fluoxetine hydrochloride (Prozac)-induced pulmonary disease","volume":"107","author":"Gonzalez-Rothi","year":"1995","journal-title":"Chest"},{"key":"10.1016\/j.taap.2014.06.014_bb0135","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1399-0004.2009.01325.x","article-title":"Respiratory disease in Niemann\u2013Pick type C2 is caused by pulmonary alveolar proteinosis","volume":"77","author":"Griese","year":"2010","journal-title":"Clin. Genet."},{"key":"10.1016\/j.taap.2014.06.014_bb0140","doi-asserted-by":"crossref","first-page":"F117","DOI":"10.1152\/ajprenal.1997.272.1.F117","article-title":"Gentamicin inhibits rat renal cortical homotypic endosomal fusion: role of megalin","volume":"272","author":"Hammond","year":"1997","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"2","key":"10.1016\/j.taap.2014.06.014_bb0145","first-page":"199","article-title":"Studies on lipids from the liver and spleen of a child (O.L.) with Niemann\u2013Pick's disease type","volume":"22","author":"Harder","year":"1984","journal-title":"C. J. Clin. Chem. Clin. Biochem."},{"issue":"8","key":"10.1016\/j.taap.2014.06.014_bb0150","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1001\/archopht.1982.01030040278015","article-title":"Amodiaquine ocular changes","volume":"100","author":"Hirst","year":"1982","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.taap.2014.06.014_bb0155","first-page":"482","article-title":"Alveolar proteinosis and phospholipidosis of the lungs","volume":"19","author":"Hook","year":"1991","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.taap.2014.06.014_bb0165","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1136\/postgradmedj-2011-130209","article-title":"Statin-induced lung injury: diagnostic clue and outcome","volume":"89","author":"Huang","year":"2013","journal-title":"Postgrad. Med. J."},{"key":"10.1016\/j.taap.2014.06.014_bb0175","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.bbrc.2008.09.121","article-title":"Drug-induced phospholipidosis is caused by blockade of mannose 6-phosphate receptor-mediated targeting of lysosomal enzymes (2008)","volume":"377","author":"Ikeda","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.taap.2014.06.014_bb0180","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1136\/ard.43.5.710","article-title":"The presence of abnormal lysosomes in lymphocytes and neutrophils during chloroquine therapy: a quantitative ultrastructural study","volume":"43","author":"Jones","year":"1984","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.taap.2014.06.014_bb0185","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0005-2760(89)90078-7","article-title":"Fluorescence studies on binding of amphiphilic drugs to isolated lamellar bodies: relevance to phospholipidosis","volume":"1004","author":"Joshi","year":"1989","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.taap.2014.06.014_bb0170","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/BF00690352","article-title":"Morphological changes in CNS of rats treated with perhexiline maleate (Pexid)","volume":"42","author":"Jung","year":"1978","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.taap.2014.06.014_bb0190","doi-asserted-by":"crossref","first-page":"24584","DOI":"10.1074\/jbc.M803715200","article-title":"Niemann\u2013Pick type C1 functions in regulating lysosomal amine content","volume":"283","author":"Kaufmann","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.taap.2014.06.014_bb0195","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3109\/01913123.2012.751950","article-title":"Hydroxychloroquine-induced phospholipidosis in a case of SLE: the wolf in zebra clothing","volume":"37","author":"Khubchandani","year":"2013","journal-title":"Ultrastruct. Pathol."},{"issue":"6672","key":"10.1016\/j.taap.2014.06.014_bb0200","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/32440","article-title":"A lipid associated with the anitphospholipid syndrome regulates endosome structure and function","volume":"392","author":"Kobayashi","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.taap.2014.06.014_bb0205","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1126\/science.7403864","article-title":"Testosterone-mediated sexual dimorphism of mitochondria and lysosomes in the mouse kidney proximal tubules","volume":"209","author":"Koenig","year":"1980","journal-title":"Science"},{"key":"10.1016\/j.taap.2014.06.014_bb0210","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000315101","article-title":"Functional inhibitors of acid sphingomyelinase (FIASMAs): a novel pharmacological group of drugs with broad clinical applications","volume":"26","author":"Kornhuber","year":"2010","journal-title":"Cell. Physiol. Biochem."},{"issue":"3","key":"10.1016\/j.taap.2014.06.014_bb0215","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1183\/09031936.02.00258802","article-title":"Statin-induced fibrotic nonspecific interstitial pneumonia","volume":"19","author":"Lantuejoul","year":"2002","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.taap.2014.06.014_bb0225","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1136\/hrt.2005.063818","article-title":"The heart in Andreson\u2013Fabry disease and other lysosomal storage disorders","volume":"93","author":"Linhart","year":"2007","journal-title":"Heart"},{"key":"10.1016\/j.taap.2014.06.014_bb0235","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1600-0854.2010.01032.x","article-title":"Lipids on trial: the search for the offending metabolite in Niemann\u2013Pick type C disease","volume":"11","author":"Lloyd-Evans","year":"2010","journal-title":"Traffic"},{"key":"10.1016\/j.taap.2014.06.014_bb0230","doi-asserted-by":"crossref","first-page":"32451","DOI":"10.1074\/jbc.M607281200","article-title":"Saposin A mobilizes lipids from low cholesterol and high bis(monoacylglycerol)phosphate-containing membranes","volume":"281","author":"Locatelli-Hoops","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.taap.2014.06.014_bb0240","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/brain\/118.1.119","article-title":"Neurofibrillary tangles in Niemann\u2013Pick disease type C","volume":"118","author":"Love","year":"1995","journal-title":"Brain"},{"key":"10.1016\/j.taap.2014.06.014_bb0250","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/0006-2952(78)90435-5","article-title":"Lipidosis induced by amphiphilic cationic drugs","volume":"27","author":"L\u00fcllmann","year":"1978","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.taap.2014.06.014_bb0245","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/BF00688943","article-title":"Lipidosis-like alterations in spinal cord and cerebellar cortex of rats treated with chlorphentermine or tricyclic anti-depressants","volume":"35","author":"L\u00fcllmann-Rauch","year":"1976","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.taap.2014.06.014_bb0255","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1161\/ATVBAHA.113.301857","article-title":"Bis(monoacylglycerol)phosphate accumulation in macrophages induces intracellular cholesterol redistribution, attenuates liver-x receptor\/ATP-binding cassette transporter A1\/ATP-binding cassette transporter G1 pathway, and impairs cholesterol efflux","volume":"33","author":"Luquain-Costaz","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.taap.2014.06.014_bb0265","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1093\/oxfordjournals.jbchem.a131824","article-title":"Studies on drug-induced lipidosis VIII. Correlation between drug accumulation and acidic phospholipids","volume":"82","author":"Matsuzawa","year":"1977","journal-title":"J. Biochem."},{"key":"10.1016\/j.taap.2014.06.014_bb0270","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/nature04399","article-title":"Role of cholesterol and lipid organization in disease","volume":"438","author":"Maxfield","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.taap.2014.06.014_bb0275","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/00125817-200109000-00003","article-title":"Clinical\u2013biochemical correlation in molecularly characterized patients with Niemann\u2013Pick type C","volume":"3","author":"Meiner","year":"2001","journal-title":"Genet. Med."},{"issue":"3","key":"10.1016\/j.taap.2014.06.014_bb0280","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1177\/0192623311432290","article-title":"Phospholipidosis in rats treated with amiodarone: serum biochemistry and whole genome micro-array analysis supporting the lipid traffic jam hypothesis and the subsequent rise of the biomarker BMP","volume":"40","author":"Mesens","year":"2012","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.taap.2014.06.014_bb0285","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1086\/324068","article-title":"Niemann\u2013Pick disease type C: spectrum of HE1 mutations and genotype\/phenotype correlations in the NPC2 group","volume":"69","author":"Millat","year":"2001","journal-title":"Am. J. Hum. Genet."},{"issue":"2","key":"10.1016\/j.taap.2014.06.014_bb0290","first-page":"239","article-title":"Varied pulmonary lesions with intra-alveolar large lamellar bodies in an autopsy case with busulfan therapy","volume":"27","author":"Miyashita","year":"1977","journal-title":"Acta Pathol. Jpn."},{"issue":"8","key":"10.1016\/j.taap.2014.06.014_bb0295","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1111\/j.1476-5381.2009.00320.x","article-title":"Intracellular sequestration of amiodarone: role of vacuolar ATPase and macroautophagic transition of the resulting vacuolar cytopathology","volume":"157","author":"Morissette","year":"2009","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.taap.2014.06.014_bb0300","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1053\/hupa.2003.36","article-title":"Chloroquine-induced phospholipidosis of the kidney mimicking Fabry's disease: case report and review of the literature","volume":"34","author":"M\u00fcller-H\u00f6cker","year":"2003","journal-title":"Hum. Pathol."},{"issue":"2","key":"10.1016\/j.taap.2014.06.014_bb0305","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/hep.1840120223","article-title":"Intrahepatic cholestasis and phospholipidosis associated with the use of trimethoprim\u2013sulfamethoxazole","volume":"12","author":"Mu\u00f1oz","year":"1990","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.taap.2014.06.014_bb0310","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1128\/AAC.00354-09","article-title":"Randomized, double-blind study of the safety, tolerability, and efficacy of tafenoquine versus mefloquine for malaria prophylaxis in nonimmune subjects","volume":"54","author":"Nasveld","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.taap.2014.06.014_bb0325","series-title":"Presented at the Connecticut Separation Science Council 9th Annual Csaba Horv\u00e1th Medal Award Symposium","article-title":"Development of an HPLC-MS method for tracking specific LBPA variants in biological matrices in response to drug-induced phospholipidosis. #O34","author":"Papov","year":"2009"},{"key":"10.1016\/j.taap.2014.06.014_bb0315","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/j.bbamem.2006.08.019","article-title":"Acid ceramidase in human disease","volume":"1758","author":"Park","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.taap.2014.06.014_bb0320","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1152\/physiol.00041.2009","article-title":"Lysosomal storage disease: revealing lysosomal function and physiology","volume":"25","author":"Parkinson-Lawrence","year":"2010","journal-title":"Physiology"},{"key":"10.1016\/j.taap.2014.06.014_bb0330","series-title":"Society of Toxicology Abstract Poster No. 724","article-title":"Urinary LBPA tracks with onset and reversal of drug-induced phospholipidosis","author":"Phillips","year":"2009"},{"issue":"5","key":"10.1016\/j.taap.2014.06.014_bb0335","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1083\/jcb.201208152","article-title":"Lysosomal storage disorders: the cellular impact of lysosomal dysfunction","volume":"199","author":"Platt","year":"2012","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.taap.2014.06.014_bb0340","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1177\/088307389601100408","article-title":"Electron microscopic examination of skin biopsy as a cost-effective tool in the diagnosis of lysosomal storage diseases","volume":"11","author":"Prasad","year":"1995","journal-title":"J. Child Neurol."},{"issue":"4","key":"10.1016\/j.taap.2014.06.014_bb0345","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1517\/14740338.5.4.567","article-title":"Drug-induced phospholipidosis: issues and future directions","volume":"5","author":"Reasor","year":"2006","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.taap.2014.06.014_bb0350","doi-asserted-by":"crossref","first-page":"4099","DOI":"10.1242\/jcs.113.22.4099","article-title":"Loss of cation-independent mannose 6-phosphate receptor expression promotes accumulation of lysobisphosphatidic acid in multilamellar bodies","volume":"113","author":"Reaves","year":"2000","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.taap.2014.06.014_bb0355","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S1054-8807(02)00118-7","article-title":"Chloroquine cardiotoxicity clinicopathologic features in three patients and comparison with three patients with Fabry disease","volume":"11","author":"Roos","year":"2002","journal-title":"Cardiovasc. Pathol."},{"issue":"3","key":"10.1016\/j.taap.2014.06.014_bb0360","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/BF02531203","article-title":"Accumulation of glycerophospholipid in classical Niemann\u2013Pick disease","volume":"3","author":"Rouser","year":"1968","journal-title":"Lipids"},{"key":"10.1016\/j.taap.2014.06.014_bb0365","series-title":"Presented at the Advisory Committee for Pharmaceutical Science and Clinical Pharmacology (ACPS)","article-title":"The regulatory challenges of drug-induced phospholipidosis","author":"Sadrieh","year":"2010"},{"key":"10.1016\/j.taap.2014.06.014_bb0370","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/S0022-2275(20)41642-6","article-title":"Structure and function of lamellar bodies, lipid protein complexes involved in storage and secretion of cellular lipids","volume":"32","author":"Schmitz","year":"1991","journal-title":"J. Lipid Res."},{"issue":"5","key":"10.1016\/j.taap.2014.06.014_bb0375","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1517\/17425251003601961","article-title":"Bis(monoacylglycerol)phosphate as a non-invasive biomarker to monitor the onset and time-course of phospholipidosis with drug-induced toxicities","volume":"6","author":"Tengstrand","year":"2010","journal-title":"Expert. Opin. Drug Metab. Toxicol."},{"issue":"2","key":"10.1016\/j.taap.2014.06.014_bb1000","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF01800716","article-title":"Correction of sphingomyelinase deficiency in Niemann-Pick type C fibroblasts by removal of lipoprotein fraction from culture media","volume":"12","author":"Thomas","year":"1989","journal-title":"J. Inherit. Metab. Dis."},{"issue":"1","key":"10.1016\/j.taap.2014.06.014_bb0380","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1177\/1091581811430167","article-title":"Comparison of the diagnostic accuracy of di-22:6-bis(monoacylglycerol)phosphate and other urinary phospholipids for drug-induced phospholipidosis or tissue injury in the rat","volume":"31","author":"Thompson","year":"2012","journal-title":"Int. J. Toxicol."},{"issue":"2","key":"10.1016\/j.taap.2014.06.014_bb0385","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.toxlet.2012.07.013","article-title":"Comparison of urinary and serum levels of di-22:6-bis(monoacylglycerol)phosphate as noninvasive biomarkers of phospholipidosis in rats","volume":"213","author":"Thompson","year":"2012","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.taap.2014.06.014_bb0390","series-title":"US FDA Project in Scientific Priority Areas","article-title":"Risk assessment of drug-induced phospholipidosis in the CNS","author":"US","year":"2009"},{"issue":"7","key":"10.1016\/j.taap.2014.06.014_bb0395","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1590\/S0100-879X2008000700001","article-title":"Side effects of oxysterols: cytotoxicity, oxidation, inflammation, and phospholipidosis","volume":"41","author":"Vejux","year":"2008","journal-title":"Braz. J. Med. Biol. Res."},{"issue":"2","key":"10.1016\/j.taap.2014.06.014_bb0400","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/00003226-200103000-00023","article-title":"Corneal deposition after high-dose chloropromazine hydrochloride therapy","volume":"20","author":"Webber","year":"2001","journal-title":"Cornea"},{"issue":"1","key":"10.1016\/j.taap.2014.06.014_bb0405","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/0002-9394(80)90227-5","article-title":"Keratopathy after oral administration of tilorone hydrochloride","volume":"89","author":"Weiss","year":"1980","journal-title":"Am J. Ophthalmol."},{"key":"10.1016\/j.taap.2014.06.014_bb0410","series-title":"Presented at the Society of Toxicology Pathology (STP) Continuing Education Course on Drug-Induced Phospholipidosis","article-title":"FDA phospholipidosis working group preliminary results and developing opinions","author":"Willard","year":"2008"},{"key":"10.1016\/j.taap.2014.06.014_bb0415","series-title":"Presented at the FDA Pharmaceutical Science and Clinical Pharmacology Advisory Committee Meeting","article-title":"FDA PLWG activities on phospholipidosis: data mining, modeling and laboratory research","author":"Willard","year":"2010"},{"issue":"1\u20132","key":"10.1016\/j.taap.2014.06.014_bb0420","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ymgme.2009.06.008","article-title":"Recommendations on the diagnosis and management of Niemann\u2013Pick disease type C","volume":"98","author":"Wraith","year":"2009","journal-title":"Mol. Genet. Metab."},{"issue":"42","key":"10.1016\/j.taap.2014.06.014_bb0425","doi-asserted-by":"crossref","first-page":"11134","DOI":"10.1021\/bi801328u","article-title":"Regulation of sterol transport between membranes and NPC2","volume":"47","author":"Xu","year":"2008","journal-title":"Biochemistry"},{"issue":"3","key":"10.1016\/j.taap.2014.06.014_bb0430","first-page":"613","article-title":"Drug-induced lipidosis in human cases and in animal experiments: accumulation of an acidic glycerophospholipid","volume":"69","author":"Yamamoto","year":"1971","journal-title":"J. Biochem."},{"issue":"5","key":"10.1016\/j.taap.2014.06.014_bb0435","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/oxfordjournals.jbchem.a129695","article-title":"Studies on drug-induced lipidosis: III. Lipid composition of the liver and some other tissues in clinical cases of \u201cNiemann\u2013Pick-like-syndrome\u201d induced by 4,4\u2032-diethylaminoethoxyhexesterol","volume":"70","author":"Yamamoto","year":"1971","journal-title":"J. Biochem."},{"issue":"1","key":"10.1016\/j.taap.2014.06.014_bb0440","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/ajmg.b.30969","article-title":"Linear clinical progression, independent of age of onset, in Niemann\u2013Pick disease, type C","volume":"153B","author":"Yanjanin","year":"2010","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"issue":"7","key":"10.1016\/j.taap.2014.06.014_bb0445","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1001\/archopht.124.7.1046","article-title":"A case of tamoxifen keratopathy","volume":"124","author":"Zinchuk","year":"2006","journal-title":"Arch Opthalmol."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X14002373?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X14002373?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T20:45:45Z","timestamp":1758573945000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X14002373"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":87,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S0041008X14002373"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2014.06.014","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Di-22:6-bis(monoacylglycerol)phosphate: A clinical biomarker of drug-induced phospholipidosis for drug development and safety assessment","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2014.06.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}